Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
peptidology.co
Peptidology holds a Disclosed Labs trust grade of B (88/100), computed independently from 162 lab Certificates of Analysis (as of June 2026). That's a strong, well-documented track record. Scores come only from lab COAs; vendors can't pay to raise them.
What is Peptidology's trust score?
Peptidology scores 88/100 (Grade B) on Disclosed Labs, from 162 lab COAs (as of June 2026).
How is Peptidology's trust score calculated?
Only from lab-issued Certificates of Analysis — average purity, safety-panel coverage, lab corroboration, and forgery signals. No vendor can pay to change it, and sponsorships never affect it.
Samples
Passed
Failed
Trust score updated: June 9, 2026 · 100% pass rate
Composite score based on 162 COAs attributed to this vendor.
Mean HPLC purity across published COAs
Per-peptide coverage of the safety panels each product form requires — identity, net-content, heavy-metals and residual-solvents for raw powders, plus endotoxin and sterility for injectables. Forms aren't penalized for panels they don't need.
Lab corroboration tier — confirmed via public verify portal (90), presumptive trusted lab (85), lab resolved but unverified (75), or no lab attribution (50)
Inverse of CoaFlag count (lot collisions, hash collisions, etc.)
Composite of 162 COAs attributed to this vendor. Last recomputed 2026-06-09.
Scottsdale, AZ based; phone support Mon-Fri 9AM-3PM MST.
| Date | Peptide | Test | Result | Purity | Lab | Notes |
|---|---|---|---|---|---|---|
| May 13, 2026 | MOTS-C | HPLC purity | PASS | 99.17% | Vanguard Laboratory | Lot 1673 · Report V260422-10 002 |
| May 6, 2026 | GLP3 | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot 1673 · Report V260421-13 002 |
| Apr 24, 2026 | GLOW | HPLC purity | PASS | 99.5% | Vanguard Laboratory |
Research profiles — side effects, mechanism, and lab-tested COA data for each peptide in this vendor's catalog.
Add a live, data-driven trust badge to your site or review. It updates automatically when new COAs are indexed — no account required.
Preview
Live badge (JavaScript)
<script async src="https://www.disclosedlabs.com/widget.js" data-vendor="peptidology"></script>
Renders the dynamic grade badge. Best visual; the link is injected by script.
Static link (HTML) — best for SEO
<a href="https://www.disclosedlabs.com/vendors/peptidology.co" rel="noopener" target="_blank" style="display:inline-flex;align-items:center;gap:8px;padding:8px 12px;border:1px solid #e2e8f0;border-radius:10px;background:#fff;color:#0f172a;text-decoration:none;font:600 13px/1.25 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Helvetica,Arial,sans-serif"> ✓ Verified by Disclosed Labs — independent COA trust score </a>
A plain, crawlable dofollow link in your page source. This is the version search engines credit.
Both point to Peptidology's live profile at https://www.disclosedlabs.com/vendors/peptidology.co.
Links back to Peptidology's profile — a dofollow link (no sponsored or nofollow tagging). Score updates daily. Dark theme & options →
| ACE-031 | vial | 1mg | $169.99 | $169.99 | Sold out | 2026-07-08 | View → |
| Adamax | vial | 10mg | $59.99 | $6.00 | Sold out | 2026-07-08 | View → |
| AHK-Cu | vial | 100mg | $119.99 | $1.20 | In stock | 2026-07-08 | View → |
| AICAR | vial | 56mg | $89.99 | $1.61 | Sold out | 2026-07-08 | View → |
| AOD-9604 | vial | 5mg | $44.99 | $9.00 | In stock | 2026-07-08 | View → |
| AOD-9604 | vial | 10mg | $59.99$69.99 | $6.00 | In stock | 2026-07-08 | View → |
| AOD-9604 | vial | 7mg | $60.99 | $8.71 | In stock | 2026-07-08 | View → |
| AOD-9604 | vial | 9mg | $69.99 | $7.78 | In stock | 2026-07-08 | View → |
| ARA-290 | vial | 10mg | $54.99 | $5.50 | In stock | 2026-07-08 | View → |
| BPC-157 | vial | 11mg | $49.99 | $4.54 | In stock | 2026-07-08 | View → |
| BPC-157 | vial | 20mg | $84.99 | $4.25 | Sold out | 2026-07-08 | View → |
| BPC-157 + TB-500 | blend | 20mg | $89.95 | $4.50 | In stock | 2026-07-08 | View → |
| BPC-157 + TB-500 | blend | 40mg | $144.95 | $3.62 | Sold out | 2026-07-08 | View → |
| Cardiogen | vial | 20mg | $54.99 | $2.75 | In stock | 2026-07-08 | View → |
| Cartalax | vial | 20mg | $65.00 | $3.25 | Sold out | 2026-07-08 | View → |
| CJC-1295 | vial | 5mg | $44.99 | $9.00 | In stock | 2026-07-08 | View → |
| Cortagen | vial | 20mg | $54.99 | $2.75 | In stock | 2026-07-08 | View → |
| Dihexa | vial | 10mg | $69.99 | $7.00 | Sold out | 2026-07-08 | View → |
| DSIP | vial | 15mg | $58.99 | $3.93 | In stock | 2026-07-08 | View → |
| Epitalon | vial | 10mg | $54.99 | $5.50 | In stock | 2026-07-08 | View → |
| Epitalon | vial | 60mg | $129.95 | $2.17 | In stock | 2026-07-08 | View → |
| Follistatin 344 | vial | 1mg | $179.99 | $179.99 | In stock | 2026-07-08 | View → |
| FOXO4-DRI | vial | 10mg | $154.99 | $15.50 | In stock | 2026-07-08 | View → |
| GHK-Cu | vial | 100mg | $44.99 | $0.45 | In stock | 2026-07-08 | View → |
| GHRP-2 | vial | 10mg | $42.99 | $4.30 | In stock | 2026-07-08 | View → |
| Glutathione | vial | 1500mg | $69.99 | $0.05 | In stock | 2026-07-08 | View → |
| Gonadorelin | vial | 5mg | $39.99 | $8.00 | Sold out | 2026-07-08 | View → |
| Gonadorelin | vial | 11mg | $67.99 | $6.18 | In stock | 2026-07-08 | View → |
| IGF-1 LR3 | vial | 1mg | $86.00 | $86.00 | Sold out | 2026-07-08 | View → |
| Ipamorelin | vial | 10mg | $58.00 | $5.80 | In stock | 2026-07-08 | View → |
| KLOW Blend (GHK-Cu + BPC-157 + TB-500 + KPV) | blend | 80mg | $135.00 | $1.69 | In stock | 2026-07-08 | View → |
| KPV | vial | 10mg | $52.99 | $5.30 | In stock | 2026-07-08 | View → |
| Livagen | vial | 20mg | $54.99 | $2.75 | In stock | 2026-07-08 | View → |
| LL-37 | vial | 5mg | $45.00 | $9.00 | In stock | 2026-07-08 | View → |
| Mazdutide | vial | 10mg | $79.99 | $8.00 | Sold out | 2026-07-08 | View → |
| Melanotan I | vial | 10mg | $41.99 | $4.20 | In stock | 2026-07-08 | View → |
| Melanotan II | vial | 11mg | $42.99 | $3.91 | In stock | 2026-07-08 | View → |
| MOTS-c | vial | 10mg | $49.00 | $4.90 | In stock | 2026-07-08 | View → |
| MOTS-c | vial | 40mg | $129.99 | $3.25 | Sold out | 2026-07-08 | View → |
| NAD+ | vial | 500mg | $59.99 | $0.12 | Sold out | 2026-07-08 | View → |
| NAD+ | vial | 1000mg | $82.99$89.99 | $0.08 | In stock | 2026-07-08 | View → |
| Oxytocin | vial | 10mg | $42.99 | $4.30 | Sold out | 2026-07-08 | View → |
| Pancragen | vial | 23mg | $58.99 | $2.56 | In stock | 2026-07-08 | View → |
| PE-22-28 | vial | 10mg | $49.99 | $5.00 | In stock | 2026-07-08 | View → |
| PEG-MGF | vial | 5mg | $87.00 | $17.40 | In stock | 2026-07-08 | View → |
| PNC-27 | vial | 10mg | $119.99 | $12.00 | In stock | 2026-07-08 | View → |
| PT-141 | vial | 10mg | $43.00 | $4.30 | In stock | 2026-07-08 | View → |
| Retatrutide | vial | 5mg | $54.99 | $11.00 | Sold out | 2026-07-08 | View → |
| Retatrutide | vial | 10mg | $79.00 | $7.90 | In stock | 2026-07-08 | View → |
| Retatrutide | vial | 11mg | $79.99 | $7.27 | In stock | 2026-07-08 | View → |
| Retatrutide | vial | 20mg | $139.00 | $6.95 | In stock | 2026-07-08 | View → |
| Retatrutide | vial | 30mg | $184.00 | $6.13 | In stock | 2026-07-08 | View → |
| Retatrutide | vial | 60mg | $279.00 | $4.65 | Sold out | 2026-07-08 | View → |
| Retatrutide | vial | 62.41mg | $279.00 | $4.47 | In stock | 2026-07-08 | View → |
| Selank | vial | 10mg | $41.00 | $4.10 | In stock | 2026-07-08 | View → |
| Semaglutide | vial | 10mg | $69.99 | $7.00 | Sold out | 2026-07-08 | View → |
| Semaglutide | vial | 20mg | $119.00 | $5.95 | In stock | 2026-07-08 | View → |
| Semaglutide | vial | 30mg | $165.00 | $5.50 | In stock | 2026-07-08 | View → |
| Semax | vial | 10mg | $38.00 | $3.80 | Sold out | 2026-07-08 | View → |
| Semax + Selank | blend | 20mg | $79.99 | $4.00 | Sold out | 2026-07-08 | View → |
| Semax + Selank | blend | 54mg | $129.99 | $2.41 | In stock | 2026-07-08 | View → |
| SNAP-8 | vial | 10mg | $42.99 | $4.30 | In stock | 2026-07-08 | View → |
| Survodutide | vial | 10mg | $79.99 | $8.00 | In stock | 2026-07-08 | View → |
| TB-500 | vial | 10mg | $56.99 | $5.70 | In stock | 2026-07-08 | View → |
| Tesamorelin | vial | 10mg | $75.00 | $7.50 | In stock | 2026-07-08 | View → |
| Thymalin | vial | 10mg | $54.00 | $5.40 | In stock | 2026-07-08 | View → |
| Thymosin Alpha-1 | vial | 10mg | $69.99 | $7.00 | In stock | 2026-07-08 | View → |
| Tirzepatide | vial | 10mg | $69.00 | $6.90 | In stock | 2026-07-08 | View → |
| Tirzepatide | vial | 30mg | $115.99 | $3.87 | In stock | 2026-07-08 | View → |
| Tirzepatide | vial | 60mg | $199.99 | $3.33 | In stock | 2026-07-08 | View → |
| Vasoactive Intestinal Peptide (VIP) | vial | 11mg | $71.99 | $6.54 | Sold out | 2026-07-08 | View → |
| Vesugen | vial | 20mg | $54.99 | $2.75 | In stock | 2026-07-08 | View → |
| Vilon | vial | 20mg | $54.99 | $2.75 | In stock | 2026-07-08 | View → |
Prices are scraped from peptidology.coand may lag the live site. All prices are single-vial / pre-bulk list prices — bulk or bundle deals may be lower. $/mg is derived from the listed strength. “Updated” is when we last verified each listing.
We are continuously testing more products. Scores update with each new result.
Read our scoring methodology →Trust scores are computed from indexed Certificates of Analysis — vendor-published, and lab-confirmed where a lab copy verifies them — using a fixed, versioned methodology (v16). They are not based on independent blind-purchase testing, and no vendor can pay for placement or a higher score. How we score · How we make money
Business CPaaS phone (-0.02), No business entity (-0.03), Lab-confirmed (0.02)
Sources: RDAP/WHOIS for domain data, Twilio Lookup for phone classification, Google Places for address verification. Crawl runs weekly. Signals are independent of vendor-supplied data.
| Lot 1673 · Report V260403-12 002 |
| Apr 21, 2026 | KLOW | HPLC purity | PASS | 99.5% | Vanguard Laboratory | Lot 1673 · Report V260421-13 003 |
| Apr 21, 2026 | TB-500 | HPLC purity | PASS | 99.39% | Vanguard Laboratory | Lot 1673 · Report V260421-13 001 |
| Apr 4, 2026 | Epithalon | HPLC purity | PASS | 99.59% | Vanguard Laboratory | Lot 1673 · Report V260403-12 001 |
| Mar 31, 2026 | GLP3 | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot 1672 · Report V260313-11 001 |
| Mar 26, 2026 | Follistatin-334 | HPLC purity | PASS | 99.5% | Vanguard Laboratory | Lot 1668 · Report V251218-9 002 |
| Mar 25, 2026 | FOXO4-DRI | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot 1671 · Report V260212-8009 |
| Mar 25, 2026 | GLP2-T | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot 1672 · Report V260325-11 001 |
| Mar 25, 2026 | Pinealon | HPLC purity | PASS | 99.15% | Vanguard Laboratory | Lot 1671 · Report V260212-8 001 |
| Mar 23, 2026 | Tesamorelin/Ipamorelin | HPLC purity | PASS | 99.34% | Vanguard Laboratory | Lot 1671 · Report V260303-10 003 |
| Mar 23, 2026 | Gonadorelin | HPLC purity | PASS | 99.16% | Vanguard Laboratory | Lot 1671 · Report V260303-10 001 |
| Mar 20, 2026 | GHK-Cu | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot 1672 · Report V260319-16 002 |
| Mar 16, 2026 | BPC-157/TB-500 | HPLC purity | PASS | 99.5% | Vanguard Laboratory | Lot 1672 · Report V260313-16 003 |
| Mar 16, 2026 | KPV | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot 1672 · Report V260313-16 004 |
| Mar 16, 2026 | MOTS-C | HPLC purity | PASS | 99.09% | Vanguard Laboratory | Lot 1672 · Report V260316-26 003 |
| Mar 16, 2026 | GHRP-2 | HPLC purity | PASS | 99.03% | Vanguard Laboratory | Lot 1672 · Report V260313-16 002 |
| Mar 9, 2026 | Ipamorelin | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot 1671 · Report V260209-26 002 |
| Feb 26, 2026 | Semax/Selank | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot 1670 · Report V260129-7 003 |
| Feb 24, 2026 | AOD-9604 | HPLC purity | PASS | 99.03% | Vanguard Laboratory | Lot 1671 · Report V260210-16 002 |
| Feb 24, 2026 | CJC-1295/Ipamorelin | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot 1668 · Report V251218-9 001 |
| Feb 24, 2026 | NAD+ | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot 1669 · Report V260119-8 009 |
| Feb 19, 2026 | GLOW | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot 1671 · Report V260219-20 002 |
| Feb 19, 2026 | GHK-Cu | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot 1671 · Report V260219-20 001 |
| Feb 15, 2026 | SNAP-8 | HPLC purity | PASS | 99.04% | Vanguard Laboratory | Lot 1669 · Report V260129-5 |
| Feb 15, 2026 | KLOW | HPLC purity | PASS | 99.5% | Vanguard Laboratory | Lot 1669 · Report V260127-1 002 |
| Feb 15, 2026 | Sermorelin | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot 1669 · Report V260127-1 001 |
| Feb 15, 2026 | Sermorelin | HPLC purity | PASS | 99.37% | Vanguard Laboratory | Lot 1668 · Report V260129-4 |
| Feb 13, 2026 | Livagen | HPLC purity | PASS | 99.05% | Vanguard Laboratory | Lot 1671 · Report V260212-8 008 |
| Feb 13, 2026 | Vilon | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot 1671 · Report V260212-8 002 |
| Feb 13, 2026 | Cardiogen | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot 1671 · Report V260212-8 005 |
| Feb 13, 2026 | Vesugen | HPLC purity | PASS | 99.53% | Vanguard Laboratory | Lot 1671 · Report V260212-8 003 |
| Feb 13, 2026 | Cortagen | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot 1671 · Report V260212-8 004 |
| Feb 13, 2026 | Pancragen | HPLC purity | PASS | 99.02% | Vanguard Laboratory | Lot 1671 · Report V260212-8 006 |
| Feb 12, 2026 | Cartalax | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot 1671 · Report V260212-8 007 |
| Feb 9, 2026 | CJC-1295 no DAC/Ipamorelin | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot 1672 · Report V260209-26 001 |
| Feb 6, 2026 | Semax | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot 1669 · Report V260120-9 002 |
| Feb 4, 2026 | Thymosin Alpha-1 | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot 1669 · Report V260120-9 001 |
| Feb 4, 2026 | Epithalon | HPLC purity | PASS | 99.27% | Vanguard Laboratory | Lot 1669 · Report V260119-8 006 |
| Feb 4, 2026 | Tesamorelin | HPLC purity | PASS | 99.46% | Vanguard Laboratory | Lot 1669 · Report V260119-8 007 |
| Feb 4, 2026 | LL-37 | HPLC purity | PASS | 99.47% | Vanguard Laboratory | Lot 1669 · Report V260119-8 005 |
| Feb 4, 2026 | MOTS-c | HPLC purity | PASS | 99.36% | Vanguard Laboratory | Lot 1669 · Report V260116-3 002 |
| Feb 4, 2026 | Semax/Selank | HPLC purity | PASS | 99.08% | Vanguard Laboratory | Lot 1671 · Report V260204-10 001 |
| Feb 4, 2026 | CJC-1295/Ipamorelin | HPLC purity | PASS | 99.35% | Vanguard Laboratory | Lot 1669 · Report V260116-3 001 |
| Feb 4, 2026 | GLP3-R | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot 1669 · Report V260119-8 001 |
| Feb 4, 2026 | Selank | HPLC purity | PASS | 99.02% | Vanguard Laboratory | Lot 1671 · Report V260204-10 004 |
| Feb 4, 2026 | PT-141 | HPLC purity | PASS | 99.04% | Vanguard Laboratory | Lot 1669 · Report V260119-8 003 |
| Feb 4, 2026 | GLOW | HPLC purity | PASS | 99.5% | Vanguard Laboratory | Lot 1669 · Report V260116-3 003 |
| Jan 30, 2026 | MOTS-C | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot 1671 · Report V260130-11 002 |